Background:
This study aimed to assess the clinical
significance of generating a volumetric stent expansion index for tapering
lesions through intravascular ultrasound (IVUS). Previous IVUS studies have used
minimal stent area (MSA) to predict adverse outcomes.
Methods:
A total of
251 tapering lesions were treated in this study via IVUS guidance in 232
patients. Eight stent expansion indices were evaluated to determine the
association of these indices with device-oriented clinical endpoints (DoCEs)
after two-year follow-ups. These were the ILUMIEN III and IV standards, the
ULTIMATE (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in
“All-Comers” Coronary Lesions) standard, the IVUS-XPL (Impact of Intravascular
Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions)
standard, the minimal volumetric expansion index (MVEI) using the Huo-Kassab or
linear model, the MSA/vessel area at the MSA cross-section, the traditional stent
expansion (MSA/mean proximal and distal reference lumen cross-sectional area),
and MSA.
Results:
The MVEI was the only stent expansion index that
correlated significantly with the two-year DoCEs (hazard ratio [HR], 1.91; 95%
confidence interval [CI]: 1.16–3.96;
p
= 0.028). In the ROC analysis,
the area under the curve for the MVEI was
0.71 (
p
= 0.002), with an optimal cut-off value of 62.2 for predicting
the DoCEs.
Conclusions:
This is the first study to use IVUS for tapering
lesions and demonstrate that the MVEI is an independent predictor of two-year
DoCEs.